Your browser doesn't support javascript.
loading
Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease / 대한소화기학회지
The Korean Journal of Gastroenterology ; : 3-10, 2014.
Article in Korean | WPRIM | ID: wpr-155062
ABSTRACT
The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. Surveillance colonoscopy has not been shown to prolong survival and rates of interval cancer are reported to be high. Continuing colonic inflammation has been shown to be important in the development of colorectal cancer and therefore anti-inflammatory agents such as the 5-aminosalicylates and immunomodulators have been considered as potential chemopreventive agents. This review focuses on various chemopreventive agents that have been clearly shown to reduce the risk of colorectal adenoma and cancer in the patients with inflammatory bowel disease.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ursodeoxycholic Acid / Colorectal Neoplasms / Inflammatory Bowel Diseases / Chemoprevention / Mesalamine / Folic Acid / Immunosuppressive Agents / Anti-Inflammatory Agents Language: Korean Journal: The Korean Journal of Gastroenterology Year: 2014 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Ursodeoxycholic Acid / Colorectal Neoplasms / Inflammatory Bowel Diseases / Chemoprevention / Mesalamine / Folic Acid / Immunosuppressive Agents / Anti-Inflammatory Agents Language: Korean Journal: The Korean Journal of Gastroenterology Year: 2014 Type: Article